Key facts
- Notable investors include Zhongjianxin Group, Wanbang Biopharmaceuticals Co..
- Status: Privately Held (backing).
- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for DDSome Lab
- ·The full record, as it builds
Funding rounds
No funding rounds for DDSome Lab are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About DDSome Lab
Manufacturer of pharmaceutical formulations intended to improve drug delivery and therapeutic performance. The company offers lipid-based carriers, albumin-bound systems, and sustained-release microsphere technologies, enabling enhanced treatment outcomes across oncology, diagnostic imaging, anesthesia, and pain management sectors.
- Sector
- Healthcare
- HQ
- Shanghai, China
- Founded
- 2015
- Website
- ddsome.cn/
- Ownership
- Privately Held (backing)
DDSome Lab doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in DDSome Lab shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on DDSome Lab in its N-PORT filings yet. We sweep new filings monthly.